Authors:
TENBERGE RJM
BUYSMANN S
VANDIEPEN FNJ
SURACHNO S
PALS ST
Citation: Rjm. Tenberge et al., INCREASED EXPRESSION OF ICAM-1 AND VCAM-1 IN THE SKIN AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, Transplantation proceedings, 29(1-2), 1997, pp. 325-327
Authors:
BUYSMANN S
HACK CE
VANDIEPEN FNJ
SURACHNO J
TENBERGE IJM
Citation: S. Buysmann et al., ADMINISTRATION OF OKT3 AS A 2-HOUR INFUSION ATTENUATES FIRST-DOSE SIDE-EFFECTS, Transplantation, 64(11), 1997, pp. 1620-1623
Authors:
BUYSMANN S
SCHELLEKENS PTA
TAX WJM
TENBERGE IJM
Citation: S. Buysmann et al., DIFFERENT CD3 T CELL-RECEPTOR MONOCLONAL-ANTIBODIES HAVE DISTINCT CAPACITIES TO INDUCE ADHESION OF T-LYMPHOCYTES TO ENDOTHELIUM/, The Journal of laboratory and clinical medicine, 130(1), 1997, pp. 91-101
Authors:
BUYSMANN S
VANDIEPEN FNJ
SURACHNO S
PALS ST
TENBERGE RJM
Citation: S. Buysmann et al., INCREASED DERMAL EXPRESSION OF ICAM-1 AND VCAM-1 AFTER ADMINISTRATIONOF OKT3 IN MAN, Clinical nephrology, 46(2), 1996, pp. 84-91
Authors:
TENBERGE RJM
BUYSMANN S
VANDIEPEN FNJ
SURACHNO S
HACK CE
Citation: Rjm. Tenberge et al., CONSEQUENCES OF OKT3 ADMINISTRATION VIA CONTINUOUS-INFUSION AS COMPARED TO BOLUS INFUSION, Transplantation proceedings, 28(6), 1996, pp. 3217-3220
Authors:
WOLBINK GJ
BROUWER MC
BUYSMANN S
TENBERGE IJM
HACK CE
Citation: Gj. Wolbink et al., CRP-MEDIATED ACTIVATION OF COMPLEMENT IN-VIVO - ASSESSMENT BY MEASURING CIRCULATING COMPLEMENT-C-REACTIVE PROTEIN COMPLEXES, The Journal of immunology, 157(1), 1996, pp. 473-479
Authors:
BUYSMANN S
BEMELMAN FJ
SCHELLEKENS PTA
VANKOOYK Y
FIGDOR CG
TENBERGE IJM
Citation: S. Buysmann et al., ACTIVATION AND INCREASED EXPRESSION OF ADHESION MOLECULES ON PERIPHERAL-BLOOD LYMPHOCYTES IS A MECHANISM FOR THE IMMEDIATE LYMPHOCYTOPENIA AFTER ADMINISTRATION OF OKT3, Blood, 87(1), 1996, pp. 404-411
Authors:
BUYSMANN S
HACK CE
VANDIEPEN FNJ
WILMINK JM
SURACHNO S
TENBERGE RJM
Citation: S. Buysmann et al., ADMINISTRATION OF OKT3 VIA CONTINUOUS-INFUSION ATTENUATES FIRST-DOSE SIDE-EFFECTS, Kidney international, 48(4), 1995, pp. 1368-1369
Authors:
BEMELMAN FJ
BUYSMANN S
YONG SL
VANDIEPEN FNJ
SURACHNO S
WILMINK JM
SCHELLEKENS PTA
TENBERGE RJM
Citation: Fj. Bemelman et al., BIPHASIC GRANULOCYTOPENIA AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, Kidney international, 47(4), 1995, pp. 1218-1218
Authors:
BUYSMANN S
VANDIEPEN FNJ
YONG SL
SURACHNO S
SCHELLEKENS PTA
TENBERGE RJM
Citation: S. Buysmann et al., MECHANISM OF LYMPHOCYTOPENIA FOLLOWING ADMINISTRATION OF CORTICOSTEROIDS, Transplantation proceedings, 27(1), 1995, pp. 871-872
Citation: Fj. Bemelman et al., BIPHASIC GRANULOCYTOPENIA AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, The Journal of laboratory and clinical medicine, 126(6), 1995, pp. 571-579
Authors:
BEMELMAN FJ
BUYSMANN S
SURACHNO J
WILMINK JM
SCHELLEKENS PTA
TENBERGE IJM
Citation: Fj. Bemelman et al., PRETREATMENT WITH DIVIDED DOSES OF STEROIDS STRONGLY DECREASES SIDE-EFFECTS OF OKT3, Kidney international, 46(6), 1994, pp. 1674-1679
Authors:
BEMELMAN FJ
SCHELLEKENS PTA
BUYSMANN S
VANDIEPEN F
SURACHNO S
TENBERGE RJM
Citation: Fj. Bemelman et al., MODULATING SIDE-EFFECTS OF OKT3 BY VARIATION OF THE TIME POINT OF METHYLPREDNISOLONE (MPNS) ADMINISTRATION - POSTPONEMENT AND PUT OFF, Kidney international, 46(5), 1994, pp. 1465-1465
Authors:
BUYSMANN S
BEMELMAN FJ
VANDIEPEN FNJ
YONG SL
SURACHNO S
SCHELLEKENS PTA
TENBERGE RJM
Citation: S. Buysmann et al., ADHESION MOLECULES ON PERIPHERAL-BLOOD LYMPHOCYTES FOLLOWING THE FIRST OKT3 ADMINISTRATION, Kidney international, 46(5), 1994, pp. 1468-1468
Authors:
BEMELMAN FJ
BUYSMANN S
WILMINK JM
SURACHNO S
HACK CE
SCHELLEKENS PTA
TENBERGE RJM
Citation: Fj. Bemelman et al., EFFECTS OF DIVIDED DOSES OF STEROIDS ON SIDE-EFFECTS, CYTOKINES, AND ACTIVATION OF COMPLEMENT AND GRANULOCYTES, COAGULATION AND FIBRINOLYSIS AFTER OKT3, Transplantation proceedings, 26(6), 1994, pp. 3096-3097
Authors:
BUYSMANN S
VANDIEPEN FNJ
VANKOOYK Y
TENBERGE RJM
Citation: S. Buysmann et al., THE INFLUENCE OF OKT3 ON EXPRESSION OF LYMPHOCYTE ADHESION MOLECULES IN-VITRO, Transplantation proceedings, 26(6), 1994, pp. 3249-3250